Talk:Tigilanol tiglate

This is the talk page for discussing improvements to the Tigilanol tiglate article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low	This article has been rated as Low-importance on the project's importance scale.

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tigilanol tiglate.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Untitled

Presumably EBC-46 is the same compound as EBI-46 listed in the patent, but stereochemistry is not given (and obviously very important given the structure), and the chemical name is definitely not IUPAC standard! Meodipt (talk) 12:57, 2 February 2011 (UTC)[reply]

Stereochemistry is given on PubChem for a closely related natural product Mancinellin, so for the time being I have redrawn the structure with the same stereochemistry for EBC-46 (plus missing methyl group). Meodipt (talk) 22:45, 2 February 2011 (UTC)[reply]

Considering Intra-lesional injection of the novel PKC activator EBC-46 rapidly ablates tumors in mouse models. -- should this article state that EBC-46 is an activator or modulator, not a regulator as it presently states? Zipf (talk) 03:03, 6 April 2015 (UTC)[reply]

News Sources

A couple news source links if anyone wants to use them:

-Radical Mallard (talk) 11:10, 3 May 2017 (UTC)[reply]